TORONTO, July 24, 2024 /CNW/ - MyChoice, a Toronto-based Insurtech company, has released an insurance assistant that allows users in the US and Canada to receive real-time life insurance quotes while ...
Myriad Genetics, Inc. MYGN recently submitted a supplementary premarket approval (sPMA) application to the FDA for its myChoice CDx test. This will enable the identification of women suffering from ...
The filing comes as recent upgrades to NCCN guidelines expand the role of testing in the treatment of ovarian cancer. Myriad Genetics this week submitted the first part of its application to the FDA ...
The University of Chicago’s myCHOICE (Chicago Options in Career Empowerment) program, which launched in 2014 to broaden experiences in scientific training and career exploration for PhD students, has ...
Myriad Genetics, Inc. MYGN recently announced the receipt of additional reimbursement in Japan for its myChoice Diagnostic System. Notably, the test aids in identifying patients with advanced ovarian ...
NEW YORK, Jan. 20, 2026 /PRNewswire/ -- TIAA today announced the launch of TIAA MyChoice MYGA, a multi-year guaranteed annuity (MYGA), offering greater choice as well as secure, competitive, ...
SALT LAKE CITY, Utah, May 29, 2015 - Myriad Genetics, Inc. (NASDAQ: MYGN) today announced new clinical studies on its myChoice HRD companion diagnostic test at the 2015 American Society of Clinical ...
SALT LAKE CITY, May 11, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results